We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Henoch-Schönlein purpura following COVID-19 vaccine in a child: a case report.
- Authors
Casini, Francesca; Magenes, Vittoria Carlotta; De Sanctis, Marina; Gattinara, Maurizio; Pandolfi, Marco; Cambiaghi, Stefano; Zuccotti, Gian Vincenzo; Fabiano, Valentina
- Abstract
Background: Henoch-Schönlein purpura (HSP) is an IgA-mediated small vessel vasculitis, typical of childhood. It's a self-limiting disease and it affects different systems. HSP is characterized by dermatological, abdominal, joint and renal clinical manifestations. This condition usually occurs upon infections, mainly upper respiratory tract ones, medications, vaccinations and malignancies. Case presentation: We describe the case of a 11 year-old girl who developed a urticarial rash 12 days after the first dose of Pfizer-BioNTech BNT16B2b2 mRNA vaccine and a clear picture of Henoch Schönlein purpura 5 days after administration of the second dose of the same vaccine. Conclusion: To our knowledge, this is the first description of a pediatric patient with Henoch-Schönlein purpura occurring in association with vaccination against COVID-19.
- Subjects
SCHOENLEIN-Henoch purpura; COVID-19 vaccines; RISK assessment; URTICARIA; MESSENGER RNA; DRUG side effects; CHILDREN
- Publication
Italian Journal of Pediatrics, 2022, Vol 48, Issue 1, p1
- ISSN
1720-8424
- Publication type
Article
- DOI
10.1186/s13052-022-01351-1